The TRIPS Waiver Saga and Global Health Equity

This chapter explores the TRIPS Waiver proposal spearheaded by South Africa and India during the COVID-19 pandemic, aimed at easing intellectual property rules to improve access to essential medicines. It delves into the opposition from wealthier nations and critiques the WTO's structure while raising ethical questions about the commodification of life-saving technologies.